Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aratana Therapeutics Inc (NASDAQ:PETX)

8.93
Delayed Data
As of 3:59pm ET
 -0.35 / -3.77%
Today’s Change
2.56
Today|||52-Week Range
10.45
+60.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.00123.0K767.0K678.0K
 
 
 
 
Cost of Goods Sold0.0092.0K253.0K153.0K
 
 
 
 
Depreciation And Amortization13.0K396.0K2.0M1.8M
 
 
 
 
 
 
Operating ExpensesGross Income-13.0K-365.0K-1.5M-1.3M
 
 
 
 
 
General Expenses10.3M17.8M36.7M46.0M
 
 
 
 
 
Research And Development7.3M10.9M20.0M25.0M
 
 
 
 
 
Total Operating Expenses10.3M18.3M39.0M48.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.3M-18.2M-38.3M-47.3M
 
 
 
 
 
Extraordinary Credit0.000.00--2.5M
 
 
Extraordinary Charge-1.5M-1.7M-3.4M-43.4M
 
 
 
 
 
Interest Expense On Debt0.00432.0K1.1M1.6M
 
 
 
 
Other Expenses121.0K477.0K2.3M3.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.6M-19.7M-40.3M-85.8M
 
 
 
 
 
Income Taxes0.00-15.5M-1.4M-1.7M
 
 
 
 
Net Income-11.6M-4.3M-38.8M-84.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.5M11.1M29.8M34.4M
 
 
 
 
 
Shares To Calculate EPS Diluted11.5M11.1M29.8M34.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.01-$0.39-$1.30-$2.45
 
 
 
 
 
EPS Diluted-$1.01-$0.39-$1.30-$2.45